Fibrin deposited in the Alzheimer's disease brain promotes neuronal degeneration

Neurobiology of Aging

Volumn 36, Issue 2, 2015, Pages 608-617

  Cortes Canteli, Marta ^a   Mattei, Larissa ^a   Richards, Allison T ^a   Norris, Erin H ^a   Strickland, Sidney ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Alzheimer's disease; Coagulation; Fibrinogen; Neurodegeneration

Indexed keywords

AMYLOID BETA PROTEIN; FIBRIN; FIBRINOGEN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE SEVERITY; FIBRIN DEPOSITION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MOUSE; NERVE CELL DEGENERATION; NEURITE; NONHUMAN; PROTEIN PROTEIN INTERACTION; THROMBOSIS; ANIMAL; BLOOD BRAIN BARRIER; BRAIN; GENETICS; INFLAMMATION; INTRACRANIAL THROMBOSIS; MEMORY DISORDERS; METABOLISM; MOLECULARLY TARGETED THERAPY; NERVE CELL; NERVE DEGENERATION; PATHOLOGY; PHYSIOLOGY; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; FIBRIN; FIBRINOGEN; HUMANS; INFLAMMATION; INTRACRANIAL THROMBOSIS; MEMORY DISORDERS; MICE, TRANSGENIC; MOLECULAR TARGETED THERAPY; NERVE DEGENERATION; NEURITES; NEURONS;

EID: 84922793499     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2014.10.030     Document Type: Article

References (65)

1. Ahn H.J., Glickman J.F., Poon K.L., Zamolodchikov D., Jno-Charles O.C., Norris E.H., Strickland S. Anovel Abeta-fibrinogen interaction inhibitor rescues altered thrombosis and cognitive decline in Alzheimer's disease mice. J.Exp. Med. 2014, 211:1049-1062.
2. Ahn H.J., Zamolodchikov D., Cortes-Canteli M., Norris E.H., Glickman J.F., Strickland S. Alzheimer's disease peptide {beta}-amyloid interacts with fibrinogen and induces its oligomerization. Proc. Natl. Acad. Sci. U. S. A 2010, 107:21812-21817.
3. Armstrong A., Mattsson N., Appelqvist H., Janefjord C., Sandin L., Agholme L., Olsson B., Svensson S., Blennow K., Zetterberg H., Kagedal K. Lysosomal network proteins as potential novel CSF biomarkers for Alzheimer's disease. Neuromolecular Med. 2014, 16:150-160.
4. Austin B.P., Nair V.A., Meier T.B., Xu G., Rowley H.A., Carlsson C.M., Johnson S.C., Prabhakaran V. Effects of hypoperfusion in Alzheimer's disease. J.Alzheimers Dis. 2011, 26(Suppl 3):123-133.
5. Barrachina M., Maes T., Buesa C., Ferrer I. Lysosome-associated membrane protein 1 (LAMP-1) in Alzheimer's disease. Neuropathol. Appl. Neurobiol. 2006, 32:505-516.
6. Brookmeyer R., Johnson E., Ziegler-Graham K., Arrighi H.M. Forecasting the global burden of Alzheimer's disease. Alzheimer's Dement. 2007, 3:186-191.
7. Chiam J.T.W., Dobson R.J.B., Kiddle S.J., Sattlecker M. Are blood-based protein biomarkers for Alzheimer's disease also involved in other brain disorders? a systematic review. J.Alzheimers Dis. 2015, 43:303-314.
8. Chishti M.A., Yang D.S., Janus C., Phinney A.L., Horne P., Pearson J., Strome R., Zuker N., Loukides J., French J., Turner S., Lozza G., Grilli M., Kunicki S., Morissette C., Paquette J., Gervais F., Bergeron C., Fraser P.E., Carlson G.A., George-Hyslop P.S., Westaway D. Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695. J.Biol. Chem. 2001, 276:21562-21570.
9. Condello C., Schain A., Grutzendler J. Multicolor time-stamp reveals the dynamics and toxicity of amyloid deposition. Sci. Rep. 2011, 1:19.
10. Cortes-Canteli M., Paul J., Norris E.H., Bronstein R., Ahn H.J., Zamolodchikov D., Bhuvanendran S., Fenz K.M., Strickland S. Fibrinogen and beta-amyloid association alters thrombosis and fibrinolysis: a possible contributing factor to Alzheimer's disease. Neuron 2010, 66:695-709.
11. Cortes-Canteli M., Zamolodchikov D., Ahn H.J., Strickland S., Norris E.H. Fibrinogen and altered hemostasis in Alzheimer's disease. J.Alzheimers Dis. 2012, 32:599-608.
12. Craig-Schapiro R., Kuhn M., Xiong C., Pickering E.H., Liu J., Misko T.P., Perrin R.J., Bales K.R., Soares H., Fagan A.M., Holtzman D.M. Multiplexed immunoassay panel identifies novel CSF biomarkers for Alzheimer's disease diagnosis and prognosis. PLoS One 2011, 6:e18850.
13. Cullen K.M., Kocsi Z., Stone J. Pericapillary haem-rich deposits: evidence for microhaemorrhages in aging human cerebral cortex. J.Cereb. Blood Flow Metab. 2005, 25:1656-1667.
14. Cullen K.M., Kócsi Z., Stone J. Microvascular pathology in the aging human brain: evidence that senile plaques are sites of microhaemorrhages. Neurobiol. Aging 2006, 27:1786-1796.
15. Davalos D., Akassoglou K. Fibrinogen as a key regulator of inflammation in disease. Semin. Immunopathol. 2012, 34:43-62.
16. de la Torre J.C. Alzheimer disease as a vascular disorder: nosological evidence. Stroke 2002, 33:1152-1162.
17. Duyckaerts C., Delatour B., Potier M.C. Classification and basic pathology of Alzheimer disease. Acta Neuropathol. 2009, 118:5-36.
18. Duyckaerts C., Potier M.C., Delatour B. Alzheimer disease models and human neuropathology: similarities and differences. Acta Neuropathol. 2008, 115:5-38.
19. Falke E., Nissanov J., Mitchell T.W., Bennett D.A., Trojanowski J.Q., Arnold S.E. Subicular dendritic arborization in Alzheimer's disease correlates with neurofibrillary tangle density. Am. J. Pathol. 2003, 163:1615-1621.
20. Fiala M., Liu Q.N., Sayre J., Pop V., Brahmandam V., Graves M.C., Vinters H.V. Cyclooxygenase-2-positive macrophages infiltrate the Alzheimer's disease brain and damage the blood-brain barrier. Eur. J. Clin. Invest. 2002, 32:360-371.
21. Franklin K.B.J., Paxinos G. The Mouse Brain in Stereotaxic Coordinates 2008, London, Elsevier, Amsterdam. third ed.
22. Gomez-Isla T., Price J.L., McKeel D.W., Morris J.C., Growdon J.H., Hyman B.T. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J.Neurosci. 1996, 16:4491-4500.
23. Gylys K.H., Fein J.A., Yang F., Wiley D.J., Miller C.A., Cole G.M. Synaptic changes in Alzheimer's disease: increased amyloid-beta and gliosis in surviving terminals is accompanied by decreased PSD-95 fluorescence. Am. J. Pathol. 2004, 165:1809-1817.
24. Hashimoto T., Ogino K., Shin R.W., Kitamoto T., Kikuchi T., Shimizu N. Age-dependent increase in lysosome-associated membrane protein 1 and early-onset behavioral deficits in APPSL transgenic mouse model of Alzheimer's disease. Neurosci. Lett. 2010, 469:273-277.
25. Hua X., Hibar D.P., Ching C.R., Boyle C.P., Rajagopalan P., Gutman B.A., Leow A.D., Toga A.W., Jack C.R., Harvey D., Weiner M.W., Thompson P.M. Unbiased tensor-based morphometry: improved robustness and sample size estimates for Alzheimer's disease clinical trials. Neuroimage 2013, 66:648-661. Alzheimer's Disease Neuroimaging, Initiative.
26. Huang Y., Mucke L. Alzheimer mechanisms and therapeutic strategies. Cell 2012, 148:1204-1222.
27. Hui K.Y., Haber E., Matsueda G.R. Monoclonal antibodies to a synthetic fibrin-like peptide bind to human fibrin but not fibrinogen. Science 1983, 222:1129-1132.
28. Humpel C. Chronic mild cerebrovascular dysfunction as a cause for Alzheimer's disease?. Exp. Gerontol. 2011, 46:225-232.
29. Iadecola C. The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia. Acta Neuropathol. 2010, 120:287-296.
30. Jantaratnotai N., Schwab C., Ryu J.K., McGeer P.L., McLarnon J.G. Converging perturbed microvasculature and microglial clusters characterize Alzheimer disease brain. Curr. Alzheimer Res. 2010, 7:625-636.
31. Jarre A., Gowert N.S., Donner L., Münzer P., Klier M., Borst O., Schaller M., Lang F., Korth C., Elvers M. Pre-activated blood platelets and a pro-thrombotic phenotype in APP23 mice modeling Alzheimer's disease. Cell. Signal 2014, 26:2040-2050.
32. Kalaria R.N., Akinyemi R., Ihara M. Does vascular pathology contribute to Alzheimer changes?. J.Neurol. Sci. 2012, 322:141-147.
33. Klohs J., Baltes C., Princz-Kranz F., Ratering D., Nitsch R.M., Knuesel I., Rudin M. Contrast-enhanced magnetic resonance microangiography reveals remodeling of the cerebral microvasculature in transgenic ArcAbeta mice. J.Neurosci. 2012, 32:1705-1713.
34. Ledesma M.D., Da Silva J.S., Crassaerts K., Delacourte A., De Strooper B., Dotti C.G. Brain plasmin enhances APP alpha-cleavage and Abeta degradation and is reduced in Alzheimer's disease brains. EMBO Rep. 2000, 1:530-535.
35. Lee S., Sato Y., Nixon R.A. Lysosomal proteolysis inhibition selectively disrupts axonal transport of degradative organelles and causes an Alzheimer's-like axonal dystrophy. J.Neurosci. 2011, 31:7817-7830.
36. Lee Y.J., Han S.B., Nam S.Y., Oh K.W., Hong J.T. Inflammation and Alzheimer's disease. Arch. Pharm. Res. 2010, 33:1539-1556.
37. Levi M., van der Poll T., Buller H.R. Bidirectional relation between inflammation and coagulation. Circulation 2004, 109:2698-2704.
38. Lipinski B., Sajdel-Sulkowska E.M. New insight into Alzheimer disease: demonstration of fibrin(ogen)-serum albumin insoluble deposits in brain tissue. Alzheimer Dis. Assoc. Disord. 2006, 20:323-326.
39. Masliah E., Mallory M., Hansen L., DeTeresa R., Alford M., Terry R. Synaptic and neuritic alterations during the progression of Alzheimer's disease. Neurosci. Lett. 1994, 174:67-72.
40. Mazza M., Marano G., Traversi G., Bria P., Mazza S. Primary cerebral blood flow deficiency and Alzheimer's disease: shadows and lights. J.Alzheimers Dis. 2011, 23:375-389.
41. Melchor J.P., Pawlak R., Strickland S. The tissue plasminogen activator-plasminogen proteolytic cascade accelerates amyloid-beta (Abeta) degradation and inhibits Abeta-induced neurodegeneration. J.Neurosci. 2003, 23:8867-8871.
42. Mosesson M.W. Fibrinogen and fibrin structure and functions. J.Thromb. Haemost. 2005, 3:1894-1904.
43. Nixon R.A., Wegiel J., Kumar A., Yu W.H., Peterhoff C., Cataldo A., Cuervo A.M. Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study. J.Neuropathol. Exp. Neurol. 2005, 64:113-122.
44. O'Mara S. The subiculum: what it does, what it might do, and what neuroanatomy has yet to tell us. J.Anat. 2005, 207:271-282.
45. Oakley H., Cole S.L., Logan S., Maus E., Shao P., Craft J., Guillozet-Bongaarts A., Ohno M., Disterhoft J., Van Eldik L., Berry R., Vassar R. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation. J.Neurosci. 2006, 26:10129-10140.
46. Paul J., Strickland S., Melchor J.P. Fibrin deposition accelerates neurovascular damage and neuroinflammation in mouse models of Alzheimer's disease. J.Exp. Med. 2007, 204:1999-2008.
47. Perez-Gracia E., Torrejon-Escribano B., Ferrer I. Dystrophic neurites of senile plaques in Alzheimer's disease are deficient in cytochrome c oxidase. Acta Neuropathol. 2008, 116:261-268.
48. Prince M., Jackson J. World Alzheimer Report 2009 2009, 1-93. Alzheimer's Disease International, London.
49. Ryu J.K., McLarnon J.G. Aleaky blood-brain barrier, fibrinogen infiltration and microglial reactivity in inflamed Alzheimer's disease brain. J.Cell. Mol. Med. 2009, 13:2911-2925.
50. Schindler J., Jung S., Niedner-Schatteburg G., Friauf E., Nothwang H.G. Enrichment of integral membrane proteins from small amounts of brain tissue. J.Neural Transm. 2006, 113:995-1013.
51. Selkoe D.J. Alzheimer's disease. Cold Spring Harb. Perspect. Biol. 2011, 3:a004457.
52. Solito E., Sastre M. Microglia function in Alzheimer's disease. Front. Pharmacol. 2012, 3:14.
53. Suh T.T., Holmback K., Jensen N.J., Daugherty C.C., Small K., Simon D.I., Potter S., Degen J.L. Resolution of spontaneous bleeding events but failure of pregnancy in fibrinogen-deficient mice. Genes Dev. 1995, 9:2020-2033.
54. Tabrizi P., Wang L., Seeds N., McComb J.G., Yamada S., Griffin J.H., Carmeliet P., Weiss M.H., Zlokovic B.V. Tissue plasminogen activator (tPA) deficiency exacerbates cerebrovascular fibrin deposition and brain injury in a murine stroke model: studies in tPA-deficient mice and wild-type mice on a matched genetic background. Arterioscler. Thromb. Vasc. Biol. 1999, 19:2801-2806.
55. Terry R.D., Masliah E., Salmon D.P., Butters N., DeTeresa R., Hill R., Hansen L.A., Katzman R. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 1991, 30:572-580.
56. Thambisetty M., Simmons A., Hye A., Campbell J., Westman E., Zhang Y., Wahlund L.O., Kinsey A., Causevic M., Killick R., Kloszewska I., Mecocci P., Soininen H., Tsolaki M., Vellas B., Spenger C., Lovestone S. Plasma biomarkers of brain atrophy in Alzheimer's disease. PLoS One 2011, 6:e28527.
57. Vafadar-Isfahani B., Ball G., Coveney C., Lemetre C., Boocock D., Minthon L., Hansson O., Miles A.K., Janciauskiene S.M., Warden D., Smith A.D., Wilcock G., Kalsheker N., Rees R., Matharoo-Ball B., Morgan K. Identification of SPARC-like 1 protein as part of a biomarker panel for Alzheimer's disease in cerebrospinal fluid. J.Alzheimers Dis. 2012, 28:625-636.
58. van Oijen M., Witteman J.C., Hofman A., Koudstaal P.J., Breteler M.M. Fibrinogen is associated with an increased risk of Alzheimer disease and vascular dementia. Stroke 2005, 36:2637-2641.
59. Viggars A.P., Wharton S.B., Simpson J.E., Matthews F.E., Brayne C., Savva G.M., Garwood C., Drew D., Shaw P.J., Ince P.G. Alterations in the blood brain barrier in ageing cerebral cortex in relationship to Alzheimer-type pathology: a study in the MRC-CFAS population neuropathology cohort. Neurosci. Lett. 2011, 505:25-30.
60. Weisel J.W. Fibrinogen and fibrin. Adv. Protein Chem. 2005, 70:247-299.
61. Wirths O., Bayer T.A. Neuron loss in transgenic mouse models of Alzheimer's disease. Int. J. Alzheimers Dis. 2010, 2010. pii: 723782.
62. Xu G., Zhang H., Zhang S., Fan X., Liu X. Plasma fibrinogen is associated with cognitive decline and risk for dementia in patients with mild cognitive impairment. Int. J. Clin. Pract. 2008, 62:1070-1075.
63. Yang H., Lyutvinskiy Y., Herukka S.K., Soininen H., Rutishauser D., Zubarev R.A. Prognostic polypeptide blood plasma biomarkers of Alzheimer's disease progression. J.Alzheimers Dis. 2014, 40:659-666.
64. Zamolodchikov D., Strickland S. Abeta delays fibrin clot lysis by altering fibrin structure and attenuating plasminogen binding to fibrin. Blood 2012, 119:3342-3351.
65. Zilkova M., Koson P., Zilka N. The hunt for dying neurons: insight into the neuronal loss in Alzheimer's disease. Bratisl. Lek. Listy 2006, 107:366-373.